Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK2 | O96017 | 16/20 | 0.60 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.53 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.50 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.50 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4314154 | 0.92 | DGAT1 (0.53) | CHEK2DGAT1ITGB1ITGA4ITGB7 | |
| SCHEMBL1248424 | 0.86 | DGAT1 (0.67) | CHEK2DGAT1ITGB1ITGA4ITGB7 | |
| SCHEMBL4011603 | 0.82 | DGAT1 (0.57) | CHEK2DGAT1HDAC3HDAC6 | |
| SCHEMBL1251104 | 0.82 | DGAT1 (0.79) | CHEK2DGAT1ITGB1ITGA4ITGB7 | |
| SCHEMBL1250981 | 0.80 | DGAT1 (0.58) | CHEK2DGAT1ITGB1ITGA4ITGB7 | |
| SCHEMBL3177289 | 0.78 | NR4A2 (0.58) | CHEK2DGAT1ITGB1ITGA4ITGB7 | |
| SCHEMBL3177891 | 0.78 | DGAT1 (0.58) | CHEK2DGAT1ITGB1ITGA4ITGB7 | |
| SCHEMBL1251886 | 0.77 | DGAT1 (0.65) | CHEK2DGAT1ITGB1ITGA4ITGB7 | |
| SCHEMBL1252157 | 0.77 | DGAT1 (0.71) | CHEK2DGAT1ITGB1ITGA4ITGB7 | |
| SCHEMBL3167498 | 0.76 | DGAT1 (0.53) | CHEK2DGAT1ITGB1ITGA4ITGB7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2074089-A2 | ORGANIC COMPOUNDS | Novartis AG (CH) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008048991-A2 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2008-04-24 | — | — | WO | disclosed |